These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects. Seregin SS; Amalfitano A Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776 [TBL] [Abstract][Full Text] [Related]
26. Treatment perspectives for the lysosomal storage diseases. Grabowski GA Expert Opin Emerg Drugs; 2008 Mar; 13(1):197-211. PubMed ID: 18321157 [TBL] [Abstract][Full Text] [Related]
27. Editorial: Genetics and Gene Therapy of Lysosomial Storage Disorders. Tuttolomondo A Curr Gene Ther; 2018; 18(2):66-67. PubMed ID: 29741137 [No Abstract] [Full Text] [Related]
28. Current strategies in the management of lysosomal storage diseases. Heese BA Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002 [TBL] [Abstract][Full Text] [Related]
29. A review of gene therapy in canine and feline models of lysosomal storage disorders. Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613 [TBL] [Abstract][Full Text] [Related]
30. Treatment strategies for lysosomal storage disorders. Beck M Dev Med Child Neurol; 2018 Jan; 60(1):13-18. PubMed ID: 29090451 [TBL] [Abstract][Full Text] [Related]
31. Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword. Cohen IJ; Baris H; Mistry PK Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():58. PubMed ID: 24380122 [No Abstract] [Full Text] [Related]
32. Update on treatment of lysosomal storage diseases. Bruni S; Loschi L; Incerti C; Gabrielli O; Coppa GV Acta Myol; 2007 Jul; 26(1):87-92. PubMed ID: 17915580 [TBL] [Abstract][Full Text] [Related]